Commonwealth Hematology-Oncology — Lawrence, Massachusetts

Commonwealth Hematology-Oncology is a clinical research site located in Lawrence, Massachusetts, United States 01841.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Commonwealth Hematology-Oncology has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: GTx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lawrence

Browse all research sites in Massachusetts · View every site in Lawrence

• Lawrence General Hospital
• Lawrence Genral Hospital
• Health Quality Primary Care
• Rubix LS
• Greater Lawrence Family Health Center
• Lawrence, Massachusetts
• Commonwealth Hematology-Oncology, PC
• Commonwealth Hematology-Oncology, P.C.
• Mary Immaculate Residential
• Vinfen Corp
• City of Lawrence Mayor's Health Task Force
• Tallman Eye Associates

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Commonwealth Hematology-Oncology?

Commonwealth Hematology-Oncology has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Commonwealth Hematology-Oncology conducted?

Commonwealth Hematology-Oncology has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is Commonwealth Hematology-Oncology accredited by Crixeo Clinical Trials?

Commonwealth Hematology-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Commonwealth Hematology-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.